Intravenous leiomyomatosis with intracardiac extension depicted on computed tomography and magnetic resonance imaging scans: A report of two cases and a review of the literature

Abstract

Intravenous leiomyomatosis (IVL) is defined as a benign smooth muscle tumor, growing within systemic veins. IVL with intracaval and intracardiac extension has rarely been reported in radiological and oncological journals. The present study describes 2 cases of IVL extending from the inferior vena cava to the right atrium and ventricle, and discusses the imaging findings and differential diagnosis of this tumor entity. The two patients, who complained of palpitations, shortness of breath or syncope, were surgically treated, with complete resection of the cardiac and intracaval tumors. Pathological examinations were suggestive of IVL. The postoperative course of the two patients was uneventful, and no signs of recurrence were observed on follow-up. Computed tomography and magnetic resonance imaging played a vital role in the diagnostic process and presurgical assessment. The results of the present study indicate that IVL should be considered upon presentation of a soft mass in systemic veins, even when the mass extends to the right cardiac chambers, in female patients, particularly in patients with a history of uterine myoma.

Introduction

Intravenous leiomyomatosis (IVL) is a rare, histologically benign, smooth muscle tumor. It is typically associated with a mesenchymal tumor of the uterus with macroscopic intravascular proliferation (1). Although IVL is histologically benign, it may occasionally exhibit malignant behavior, due to its growth along the pelvic veins and the inferior vena cava (IVC), extending into the cardiac chambers and pulmonary vasculature (2). Due to its rarity and atypical clinical features, the condition may be misdiagnosed as a primary cardiac tumor or a venous thrombus, which may lead to potentially life threatening consequences. Hence, early and accurate diagnosis and appropriate treatment choices are important for the patient prognosis. Complete surgical resection (single or staged procedures) is the treatment option for IVL, as it is key to preventing recurrence (3). The present study reports 2 cases of IVL that were diagnosed using dual-source computed tomography (CT) and magnetic resonance imaging (MRI), as well as clinical and pathological examinations. A review of the English literature on IVL was also performed.

Case report

Case 1

A 46-year-old female patient was referred to the West China Hospital of Sichuan University (Chengdu, China) in December 2013, presenting with a 10-day history of palpitations and shortness of breath that were exacerbated upon exertion. Physical examination revealed slight bilateral leg edema and no other abnormalities. Echocardiography showed a mobile, solid mass in the right atrium that originated from the IVC. The lesion, which almost blocked the tricuspid valve, was initially diagnosed as atrial myxoma or thrombus. The serum levels of the tumor marker carbohydrate antigen (CA) 125 were mildly elevated (41.93 U/ml; normal value, <35 U/ml), while all other blood and biochemical markers were within the normal ranges. The patient's medical history included a myomectomy (on October 2000), with no notable family history.

Thoracic and abdominal CT scans (Somatom Definition Flash; Siemens AG, Munich, Germany) were performed with and without contrast media. On the CT scans, a filling defect was observed in the IVC and right atrium, with a soft tissue density of 20–22 HU on plain images and 28–62 HU on contrast-enhanced images. The lesion stretched into the right ventricle through the tricuspid valve, and stretched as far as the left common iliac vein and internal iliac vein inferiorly. In addition, an ill-defined mass with heterogeneous attenuation was detected in the pelvic region; the mass originated from the uterus and involved the left gonadal vein, resulting in luminal stenosis. The CT value of the pelvic lesion was 15–31 HU on plain images and 31–52 HU on contrast-enhanced images. The lesion in the right atrium and IVC appeared to be anatomically associated with the mass located in the pelvic region (Fig. 1). Furthermore, tortuous collateral veins were observed around the IVC. Cardiac cine MRI (Magnetom Trio Tim; Siemens AG) showed that the circumscribed mass moved in parallel with the cardiac motion in the right cardiac cavities. Gadolinium-enhanced MRI of the heart revealed a large streak-shaped filling defect in the IVC and right atrium that was mildly hyperintense on T1- and T2-weighted imaging (WI), and heterogeneously enhanced following contrast-enhanced scanning (Fig. 2).

Figure 1.

Case 1: Contrast-enhanced computed tomography scans. (A and B) Oblique-coronal and (C and D) sagittal reconstruction images showing a cord-like mass (arrows) in the lumen of the left iliac vein, extending to the inferior vena cava and right atrium. (A) The enhancement features of the intravenous mass were similar to those of the uterine mass (triangle).

Figure 2.

Case 1: Axial T2-weighted magnetic resonance imaging scan of the heart showing a mass with low signal intensity in the right atrium (triangle; left) and a lesion involving the inferior vena cava, which exhibited heterogeneous enhancement following contrast agent administration (arrows; right).

Considering the imaging findings, complete surgical excision of the tumor in the IVC was performed carefully through a right atriotomy and longitudinal venotomy in January 2014. The tumor had no stalk or obvious adhesion with the wall of the right atrium.

The resected gross intracaval specimen was a yellowish-white tumor with a smooth border and a tip. The tumor appeared as a sausage-shaped protrusion with a maximum diameter of ~20 cm. Immunohistochemical analysis using monoclonal antibodies revealed positivity for the smooth muscle markers desmin (Biocare Medical LLC, Concord, CA, USA) and smooth muscle actin (SMA; OriGene Technologies Inc., Rockville, MD, USA), and negativity for h-caldesmon (Epitomics, Burlingame, CA, USA), human melanoma black 45 (HMB45) and S-100 (both Leica Microsystems Inc., Buffalo Grove, IL, USA). Upon microscopy (CX31-72C02 microscope; Olympus, Corporation, Tokyo, Japan), the hematoxylin-eosin staining of tumor sections revealed smooth muscle cell proliferation without nuclear atypia or mitotic index. The MIB-1/Ki-67 (OriGene Technologies Inc.) labeling index was ~2%, confirming the non-malignant nature of the tumor. In addition, estrogen and progesterone (Epitomics) expression was detected in the nucleus (3).

The postoperative course of the patient was uneventful, and no signs of recurrence were observed at the 1-year follow-up examination in February 2015.

Case 2

A 45-year-old female patient presented to the West China Hospital of Sichuan University in November 2014 with a 4-month history of persistent palpitations and occasional syncope. The patient's past medical history consisted of a myomectomy on June 2007, with nothing of particular note in the family medical history. Upon physical examination, a diastolic murmur was auscultated in the tricuspid region. Laboratory test results were normal, with the exception of an increased level of CA 125 (56.93 U/ml). Echocardiography demonstrated a hypoechogenic mass in the right atrium and ventricle, suggesting a diagnosis of thrombi.

Contrast-enhanced CT scans performed from the chest to the pelvis revealed unilateral heterogeneous uterine masses in the right iliac vein and IVC that were indicative of multiple leiomyoma. The mass that caused almost complete occlusion of the IVC demonstrated enhancement similar to that of the uterine leiomyoma (Fig. 3). MRI of the chest and upper abdomen revealed a cord-like mass extending from the IVC into the right cardiac chambers and almost completely occupying the IVC lumen. The tumor exhibited low to intermediate signal intensity on T1WI and heterogeneous high signal intensity on T2WI, with mild enhancement observed in the late phase. The top of the mass extended from the right atrium into the right ventricle at the diastolic phase (Fig. 4). Based on these findings, the patient was diagnosed with IVL of the uterus with intravascular and cardiac extension.

Figure 3.

Case 2: Coronal (left) and sagittal (right) reconstruction images of the contrast-enhanced computed tomography scan showing that the uterine tumor had invaded the right parametrial veins and extended to the right atrium through the right common iliac vein (triangle) and inferior vena cava (arrows). The lesions exhibited an isodensity and enhancement similar to those of the adjacent hysteromyoma.

Figure 4.

Case 2: Axial (A) T1- and (B) T2-weighted fast spin-echo magnetic resonance imaging (MRI) showing a polypoid mass within the inferior vena cava (IVC; arrow), with (C and D) restricted diffusion on diffusion-weighted MRI. (D) Cardiac MRI scan showed that the distal portion of the mass had moved into the right ventricle through the tricuspid valve during diastole (triangle). (E) Contrast-enhanced MRI revealed that the tubular, serpent-like filling defect (arrows) almost completely occupied the IVC.

Total abdominal hysterectomy, bilateral salpingo-oophorectomy, and intracardiac and intravenous mass excision were performed as a two-stage procedure under cardiopulmonary bypass in April 2013 and July 2013. Gross examination of the intravascular specimen revealed a smooth, wormlike mass, 3–4 cm in circumference and 26 cm in length, with a bulbous end corresponding to the intracardiac portion that almost blocked the tricuspid valve.

The excised tumor had a white cut surface, and was rubbery and firm on palpation. Immunohistochemical analysis of the IVL cells indicated positive staining for the smooth muscle markers desmin (Biocare Medical LLC) and SMA (OriGene Technologies Inc.), and negative staining for Ki-67 (OriGene Technologies Inc.), HMB45, S-100 (both Leica Microsystems Inc.), h-caldesmon (Epitomics) and p53 (OriGene Technologies Inc.), confirming its smooth muscle nature without signs of malignancy. Nuclear estrogen and progesterone receptor expression was observed in the intravascular tumor and uterine leiomyoma. The postoperative course was uneventful. The patient continued to recover well, and at the 18-month follow-up, there was no recurrence of the symptoms or tumor, and the patient resumed normal activities thereafter.

Discussion

IVL, which was first described by Brich-Hirschfeld in 1896 (4), is a rare benign tumor that is histologically characterized by nodular masses of smooth muscle cells growing within systemic veins. It typically originates from the uterus and may involve ovarian veins. Occasionally, the tumor occurs in other intravascular locations, distant from the uterus. Durck reported the first case of IVL with intracardiac extension in 1907 (5). The tumors were described as nodular or spiral within pelvic veins and the IVC, or extending to the right cardiac chambers and bilateral pulmonary arteries (2,6,7). Two major hypotheses have been established regarding the etiology of IVL (1,8). The first hypothesis suggests that the tumor arises from the vein walls, while the second proposes that the uterine leiomyoma is a primary tumor with intravascular projections into an adjacent venous channel. Fukuyama et al (9) suggested that the tumor does not invade the vessel by breaking the venous wall, but rather stretches the vascular wall to extend along the vascular lumen, while covered in endothelium.

A review of the English literature included by PubMed between January 2000 and January 2015 was performed using the keywords ‘intravenous leiomyomatosis’ AND ‘last 15 years’[PDat], and 52 cases of IVL with CT or MRI descriptions were identified, as indicated in Table I (2,6,7,10–46). The median age of the patients was 44.8 years old (age range, 20–70 years). The majority of cases were diagnosed intraoperatively. Common initial symptoms included pelvic pain or abnormal uterine bleeding; however, certain patients presented with chest pain, palpitation, shortness of breath, dyspnea on exertion, edema of the lower extremities or even sudden mortality. The clinical signs and symptoms predominantly depended on the degree of intravascular obstruction caused by the tumor. Heart failure may result in misdiagnosis or delayed diagnosis of IVL until further examination or sudden mortality due to fatal intracardiac obstruction.

Table I.

Clinical features of all 52 cases diagnosed as intravenous leiomyomatosis.

No.	Author, year	Cases, n	Age years,	Symptoms	Extension	Treatment	Outcome	Refs.
1	Osawa et al, 2013	1	66	Asymptomatic	IVC	One-stage complete resection	No recurrence for 6 months	(10)
2	Yaguchi et al, 2010	1	70	Asymptomatic	IVC	One-stage complete resection	No recurrence for 2 years	(11)
3	Leitman et al, 2008	2	52	Transient ischemic attack	IVC, RA	One-stage complete resection	/	(12)
			49	Asymptomatic	IVC, RA	One-stage complete resection	/
4	Rispoli et al, 2010	1	60	Asymptomatic	IVC, RA	One-stage complete resection	No recurrence for 22 months	(13)
5	Bender et al, 2011	1	55	Hypertension	IVC, RA, RV	One-stage complete resection	No recurrence for 4 months	(14)
6	Ozer et al, 2005	1	43	Abdominal pain, dizziness, bilateral leg edema	IVC, RA	Refused any treatment	/	(15)
7	Liu et al, 2013	1	33	Asymptomatic	IVC, RA	One-stage complete resection	No recurrence for 13 months	(16)
8	Matos et al, 2013	1	45	Fatigue, shortness of breath and precordial discomfort	IVC, RA	Two-stage resection	/	(17)
9	Wakiyama et al, 2000	1	47	Syncopic	IVC, RA	One-stage complete resection	No recurrence for 6 months	(18)
10	Lou et al, 2011	1	42	Debilitation and engorgement of both lower extremities	IVC, RA	One-stage complete resection	/	(19)
11	Robert-Ebadi et al, 2009	1	41	Asymptomatic	IVC	One-stage complete resection	/	(20)
12	Barksdale et al, 2011	1	44	Increasing lethargy, abdominal pain, bilateral lower extremity edema, and increasing abdominal girth	IVC, hepatic veins	Two-stage resection	No recurrence for 3 months	(21)
13	Biri et al, 2008	1	31	Shortness of breath and orthopnea	IVC, RA	Refused surgery, treatment with aromatase inhibitor	Tumor size was decrease in a 6-month follow-up	(22)
14	Saitoh et al, 2004	1	47	Asymptomatic	IVC, RA	One-stage complete resection	No recurrence for 17 months	(23)
15	Harris and Karakousis et al, 2000	1	48	Shortness of breath, recurrent palpitations and dizziness	IVC, RA, RV	One-stage complete resection	No recurrence for 6 months	(24)
16	Fang et al, 2007	1	40	Dyspnea on exertion, mild leg edema, and syncope	IVC, RA	Two-stage resection	No recurrence for 6 months	(25)
17	Liu et al, 2009	6	48	Menstruation increase	IVC, RA	Two-stage resection	1 case with residual tumor, the	(26)
			41	Intermittently flustered, chest tightness	IVC, RA	Two-stage resection	other 4 cases had no recurrence (average follow-up time: 58.5±26.8 months)
			49	Edema of both lower legs, with increasing abdominal distention	IVC, RA	No surgical intervention due to serious heart and lung dysfunction
			20	Asymptomatic	IVC	One-stage complete resection
			43	Asymptomatic	IVC	One-stage complete resection
			38	Asymptomatic	IVC	One-stage complete resection
18	Clay et al, 2013	1	40	Lower abdominal and rectal discomfort	IVC, RA, RV	Two-stage resection	No recurrence for 18 months	(27)
19	Wu et al, 2009	1	39	Chest tightness and dyspnea	IVC, RA	Two-stage resection	/	(28)
20	Singh et al, 2010	1	43	Right upper abdominal pain, bloating and swelling of the left leg	IVC, RA	One-stage complete resection	/	(29)
21	Li et al, 2011	4	36	Sudden and transient syncope	IVC, RA, RV	One-stage complete resection	/	(30)
			48	Recurrent sudden syncope	IVC, RA	One-stage	/
			51	Recurrent sudden syncope	IVC, RA, RV	One-stage	/
			43	Asymptomatic	IVC, RA	One-stage	/
22	Wong et al, 2006	1	54	Acute-onset left lower limb swelling	IVC, RA	Gonadotropin-releasing hormone + one-stage complete resection + tamoxifen	A follow-up CT scan showed rapid progression of disease with intravascular tumor extending into the right atrium, abdominal lymphadenopathy, and an increase in the number and size of lung metastases	(31)
23	Peng et al, 2012	4	37,40, 43,48	2 cases of edema of the lower, extremity; 1 case of bulk-related symptoms of recurrent, leiomyoma 1 case of chest distress on breath-holding	IVC (1 case) RA (2 cases) RV (1 case)	/	/	(32)
24	Ahmed et al, 2004	1	48	Bulk-related symptoms of recurrent leiomyoma	IVC	One-stage complete resection	/	(33)
25	Bilyeu et al, 2006	1	51	Left arm discomfort and palpitations	IVC, RA	Two-stage resection	/	(34)
26	Moorjani et al, 2005	1	64	Left calf swelling	IVC, RA	One-stage complete resection and adjuvant radiotherapy	A subsequent CT scan showed recurrence of the tumor on the pelvic wall, as well as sacral metastases	(35)
27	Lai et al, 2005	1	47	Menorrhagia	IVC	Two-stage resection	/	(36)
28	Demirkiran et al, 2013	1	39	Asymptomatic	IVC, RA	One-stage complete resection	No recurrence for 4 months	(37)
29	Izzat et al, 2011	1	45	Dyspnea	IVC, RA, PA	One-stage complete resection	No recurrence for 8 months	(9)
30	Nam et al, 2003	1	46	Abdominal pain and discomfort	IVC, RA	One-stage complete resection	No recurrence for 12 months	(38)
31	Kokawa et al, 2002	1	49	Syncope	IVC, RA	One-stage complete resection	No recurrence for 17 months	(39)
32	Lee et al, 2011	1	43	Palpitation, dizziness, dyspnea, and chest pain	IVC, RA, PA	One-stage complete resection	No recurrence for 2 years	(7)
33	Rajaii-Khorasani et al, 2012	1	25	Deteriorating fatigue, dyspnea on exertion	IVC, RA, PA	One-stage complete resection	No recurrence for 2 years	(2)
34	Esmaeilzadeh et al, 2007	1	46	Worsening dyspnea on exertion	IVC, RA RV	Tamoxifen and decapeptide + reoperation 6 months later	Early recurrence was secondary to the incomplete resection	(40)
35	Elkington et al, 2005	1	53	Asymptomatic	IVC	two-stage resection	/	(41)
36	Cea-Calvo et al, 2000	1	41	Swollen legs and abdominal distension	IVC, RA	One stage complete resection	/	(42)
37	Xu et al, 2013	1	36	Shortness of breath after activities	IVC, RA	One stage complete resection	/	(43)
38	Sogabe et al, 2014	1	45	Repeated syncopal attacks	IVC, RA	One-stage complete resection	No recurrence for 10 months	(44)
39	Moniaga et al, 2012	1	44	Dyspnea and lower extremity edema	IVC, RA	Two-stage resection	Recovered well	(45)
40	Kocaoglu et al, 2003	1	43	Dyspnea, lower extremity swelling, and syncope	IVC, RA, RV	Incomplete resection	Lost to follow-up	(46)

IVC, inferior vena cava; RA, right atrium; RV, right ventricle; PA, pulmonary artery.

In the majority of the reviewed cases, the initial pathway of extension for IVL was unilateral through the common iliac veins, while certain cases exhibited IVL with intracardiac extension and concomitant uterine leiomyoma. Various unusual patterns of intravenous growth were observed in the 52 recorded tumors; the distal end of 11 tumors (21.2%) were confined to the IVC, 30 (57.7%) extended to right atrium, 8 (15.4%) to the right ventricle and 3 (5.8%) to the pulmonary arteries. Tumor mobility was recorded in 42 of these cases, however, due to the varying diameters of the tumors, adherence to the wall of the IVC or the right chambers were reported in 26 cases. The distal end of the tumor in the present cases extended intracardially to the right atrium and right ventricle. Both of these tumors moved in parallel with cardiac motion.

CT and MRI scans are the most useful imaging modalities for the diagnosis of IVL. The high-density resolution and multiplanar capability of CT, as well as the excellent soft tissue resolution of MRI, render these modalities particularly favorable for characterizing the continuity of intraluminal tumors. In the two cases in the present study, the IVLs appeared as soft masses in the right atrium and IVC on CT scans; the IVL completely occupied the IVC, iliac veins and internal iliac vein in a continuous manner in each case. A portion of the irregular uterine mass appeared to be anatomically connected to the tumor in the adjacent iliac veins. The IVLs of the two patients shared similar soft tissue density and enhanced features on CT or MRI scans with those reported in previous studies (40,47). Of the 52 cases identified in the literature, 45 (86.5%) underwent a contrast-enhanced CT scan or CT angiography. Heterogeneous enhancement of the tumors was observed in 27 (60.0%) cases, consistent with the present cases, with mildly homogeneous or no enhancement in 13 (28.9%) cases and homogeneous enhancement in 5 (11.1%) cases.

The signal intensity of the lesions on MRI depends on the number of smooth muscle cells and vessels containing hyalinized fibrous tissue (48). The tumor in case 1 of the present study was mildly hyperintense on T1WI and T2WI, whereas the tumor in case 2 had a low to intermediate signal intensity on T1WI and heterogeneous hyperintensity on T2WI; both tumors exhibited heterogeneous enhancement. There are conflicting reports with regards to the signal intensity of IVL on MRI scans; in certain studies, IVL presents as iso- to mildly hyperintense (46,48), while in others it presents as hypointense (49,50) on T1WI. The predominant findings on T2WI are heterogeneous-homogeneous hyperintense signals (46); however, Fasih et al (48) reported low signal intensity and Kang et al (49) reported isointensity to the myocardium. Of the 24 reported cases that underwent contrast-enhanced MRI scans, the intraluminal tumors exhibited mild heterogeneous enhancement in 45.8% cases, mild homogeneous enhancement in 29.2% and marked enhancement in 25.0%, while the two present cases showed mild heterogeneous enhancement. We propose that the diverse pattern of phase-based enhancement may result from the nourishing vessels of the tumor originating from the pelvic vasculature.

The differential diagnosis of IVL predominantly includes thrombi within systemic veins, leiomyosarcoma arising from the wall of the IVC, right atrial myxoma and malignant thrombosis with carcinoma (34), as these entities have similar CT or MRI characteristics to IVL. However, intravenous thrombi show no enhancement following contrast agent administration due to their lack of vascular supply. Distinguishing between IVL and leiomyosarcoma of the IVC is challenging in the early stages of the disease, however, when the latter presents with visible infiltration and invasion around structures, diagnosis becomes more simple (51). Leiomyosarcoma arises from the vascular wall, and a gap between the tumor and vascular wall may not be visible on cross-sectional CT images from a certain point of view. Furthermore, current research indicates that IVL only occurs in women (52). Right atrial myxoma typically involves the cardiac chamber and does not normally extend into the IVC. The features of malignant thrombosis are similar to those of the primary tumor and the lesion is generally considerably smaller than the IVL. In addition, malignant thrombosis is not associated with a history of uterine myoma or surgery for uterine myoma (10). Complete surgical excision of the tumor is an appropriate treatment option for IVL, and the final diagnosis is dependent on histopathological analysis.

In conclusion, IVL should be considered upon presentation of a soft mass in the systemic veins, with or without extension to the right cardiac chamber, in female patients, particularly in patients with a history of uterine myoma. Furthermore, imaging modalities able to display the precise location and full-scale extension path of the tumor, such as CT and MRI, are of great importance in the presurgical assessment of IVL.